RB
The startup has developed an analytic platform that utilizes cell-free DNA to enable early disease detection through a single blood draw. This technology facilitates the rapid development and validation of screening tests for multiple diseases, enhancing diagnostic efficiency for medical professionals.
Updated 3 months ago
Funding
$2.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed an analytic platform that utilizes cell-free DNA to enable early disease detection through a single blood draw. This technology facilitates the rapid development and validation of screening tests for multiple diseases, enhancing diagnostic efficiency for medical professionals.